The effect of tobramycin on Pseudomonas keratitis.
D000606:Amino Sugars / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D003315:Cornea / Q000382:microbiology; D004195:Disease Models, Animal; D004492:Edetic Acid / Q000494:pharmacology; D004544:El Salvador; D005122:Exudates and Transudates / Q000382:microbiology; D005839:Gentamicins / Q000494:pharmacology / Q000627:therapeutic use*; D006027:Glycosides / Q000494:pharmacology / Q000627:therapeutic use; D007267:Injections; D007634:Keratitis / Q000188:drug therapy*; D008297:Male; D008826:Microbial Sensitivity Tests; D009883:Ophthalmic Solutions; D011552:Pseudomonas Infections / Q000188:drug therapy*; D011550:Pseudomonas aeruginosa / Q000187:drug effects / Q000302:isolation & purification; D011817:Rabbits
D000606:Amino Sugars; D000900:Anti-Bacterial Agents; D005839:Gentamicins; D006027:Glycosides; D009883:Ophthalmic Solutions; D004492:Edetic Acid